The paper published by the group from New York Proton Center reported successful PBS Bragg peak FLASH planning for on 10 consecutive hepatocellular carcinoma...
Proton therapy is different from photon-based radiotherapy. Because of their unique physical properties, protons have no ‘exit’ dose and very little ‘entrance’...
The Proton Therapy Centre in Prague (PTC) is a leading global health care facility and one of the most advanced proton therapy providers in Europe. The centre...
The Texas Center for Proton Therapy brings an advanced cancer treatment to North Texas that offers more hope to cancer patients. The 63,000-square-foot center...
This study investigated the QoL of patients with Ewing sarcoma treated with PBS-PT. A PEDQOL questionnaire evaluating eight different domains was filled by the...
Published in the Green Journal, this study compared two cohorts of each 153 patients with uveal melanoma treated with fractionated stereotactic photon-RT (50 Gy...
What is on the horizon with IBA Dosimetry and Proton Therapy? Watch this webinar to learn about QA and how it will be integrated with our future developments.
This study conducted by the MD Anderson group reported clinical results of 42 children with Ewing sarcoma treated with protons to a median total dose of 54...
This study reported toxicities of 43 children with medulloblastoma treated with PBS-PT. The most common (>30% of patients) acute toxicities were radiation...
For a cohort of 219 patients with stage III NSCLC who received definitive concurrent chemoradiotherapy, 25 patients (11.4%) underwent PBSPT and 194 patients (88...